The Equine Healthcare Market size was USD 1.7 Billion in 2023 and is predicted to grow with a CAGR of 6.1% by generating a revenue of USD 2.57 Billion by 2030Equine Healthcare Market Overview
Equine healthcare plays a crucial role in identifying signs of deterioration in a horse's health. Proper care post-workout is essential for horses to facilitate cool-down and recovery, necessitating close attention to various areas such as body temperature, respiration, muscle maintenance, and leg condition. Alongside adequate feeding and exercise, maintaining overall health involves routine veterinary check-ups for vaccinations, parasite control, and dental care, as well as grooming, hoof maintenance, and protection from environmental elements. Regular monitoring for signs of illness, including changes in appetite, digestive issues, respiratory symptoms, skin abnormalities, lameness, and reluctance to move, is imperative. The industry's growth is driven by increasing demand for equine healthcare services, collaborative efforts by market participants, investments in equine racing and sports, and the rising incidence of equine diseases.To know about the Research Methodology:-Request Free Sample Report The equine healthcare market is experiencing significant growth driven by factors such as rising pet ownership, increasing concerns about animal health, and advancements in veterinary medicine. The market covers a wide range of products and services including pharmaceuticals, vaccines, diagnostic services, supplements, and healthcare equipment tailored to the specific needs of horses. As of recent, key players in the market have been focusing on research and development activities to introduce innovative products and treatment solutions, thus enhancing the overall quality of equine healthcare. Additionally, strategic collaborations, partnerships, and acquisitions have been observed among market players to expand their product portfolios and geographical presence. For instance, in 2023, Zoetis, a leading player in the animal health industry, announced the acquisition of a veterinary diagnostics company, further strengthening its position in the equine healthcare market. Similarly, ongoing investments in digital health solutions and telemedicine platforms are also contributing to market growth, allowing veterinarians to provide remote consultations and monitoring for equine patients. With the growing demand for preventive healthcare and the increasing emphasis on performance optimization in the equine industry, the Equine Healthcare Market is poised to continue in the coming years.
Equine Healthcare Market Dynamics:
Innovative Therapies Transform Equine Musculoskeletal Care is Driving Equine Healthcare Market One of the primary drivers propelling the equine healthcare market forward is the increasing trend of pet ownership. Globally, there has been a steady rise in the number of individuals who own horses as pets or companions. This growing ownership translates to a higher demand for equine healthcare products and services, as horse owners prioritize the health and well-being of their beloved animals. For instance, during the COVID-19 pandemic, there was a notable surge in pet ownership, with many individuals seeking the companionship and solace that animals provide. This surge not only bolstered the equine healthcare market but also underscored the essential role that horses play in the lives of their owners. Advancements in veterinary medicine represent another pivotal growth driver for the equine healthcare market. Continuous research and innovation in veterinary science lead to the development of new treatments, therapies, and diagnostic techniques tailored specifically for horses. Stem cell therapy, for example, has emerged as a groundbreaking treatment for musculoskeletal injuries in horses, revolutionizing the way such conditions are managed. These advancements not only improve the quality of care provided to equine patients but also open up new avenues for market growth and expansion. The integration of technology into equine healthcare has played a significant role in driving market growth. From telemedicine platforms to wearable health monitoring devices, technology has enabled veterinarians to enhance their diagnostic capabilities and improve patient care. SmartPak Equine, for instance, offers innovative wearable technology that tracks vital signs and activity levels in horses, allowing for early detection of health issues and proactive intervention. This convergence of healthcare and technology not only benefits individual horses but also contributes to the overall advancement of the equine healthcare market.Table: Horse Population Estimate Breakdown
The expanding focus on preventive healthcare has fueled demand for equine healthcare products and services. Horse owners are increasingly investing in vaccines, deworming programs, and nutritional supplements to maintain the health and well-being of their animals. Initiatives promoting vaccination campaigns against equine influenza and other contagious diseases serve to reduce disease prevalence and enhance overall equine health. By prioritizing prevention over treatment, horse owners can mitigate health risks and ensure the longevity of their animals, thus driving market growth. Furthermore, the growth of the equine sports and racing industry has had a significant impact on the equine healthcare market. Major events such as the Kentucky Derby and the Rolex Grand Slam of Show Jumping attract substantial investments in equine healthcare, as owners and trainers seek to optimize the performance and well-being of their horses. This heightened focus on performance optimization drives demand for specialized healthcare products and services tailored to the specific needs of athletic horses. As a result, the equine healthcare market continues to expand and evolve in response to the evolving needs of the industry. The market continues to evolve, stakeholders must remain agile and adaptive, leveraging emerging opportunities to drive innovation and foster sustainable growth. Ethics in Equine Healthcare: Balancing Welfare and Access Regulatory hurdles pose a significant obstacle, as stringent regulations and compliance requirements, such as those imposed by the FDA, can delay the approval process for new equine healthcare products and treatments. High treatment costs also impede market growth, as advanced therapies like stem cell therapy for musculoskeletal injuries can be prohibitively expensive for many horse owners, limiting access to innovative treatments. Limited access to veterinary services in rural areas further complicates matters, as geographic barriers and a shortage of qualified veterinarians restrict the reach of equine healthcare solutions. Moreover, resistance to technology adoption among some segments of the equine community, coupled with concerns about reliability and cost, slows the penetration of innovative technologies like wearable health monitoring devices. Economic instability, exemplified by periods of recession, can lead to reduced spending on non-essential services, impacting the demand for equine healthcare. Insurance limitations, such as inadequate coverage for specialized treatments or exclusions for pre-existing conditions, also constrain market growth by making healthcare services less accessible to horse owners. Inadequate research funding presents another challenge, as limited resources hinder the development of new equine healthcare solutions. Environmental factors, including climate change, can increase the prevalence of certain equine health issues, exacerbating the demand for healthcare resources. Additionally, competition from alternative therapies like herbal remedies and holistic treatments diverts demand away from conventional veterinary treatments, affecting market growth. The ethical concerns and animal welfare considerations may influence consumer preferences and purchasing decisions, potentially impacting the market access for certain equine healthcare products and services. For instance, Regulation No. 910 on the welfare of horses, the regulation establishes minimum standards for ensuring the welfare of horses, aiming to promote their health and well-being through proper treatment, care, and facilities. It is structured into the following sections: I. Objectives and definitions; II. Assessment and oversight; III. Care and treatment; IV. Infrastructure; V. Enforcement and commencement. The regulation addresses various aspects such as exercise, socialization, handling, riding, training, competitions, feeding, watering, health management, euthanasia, stable conditions, and disease control. Non-compliance with these standards result in penalties as outlined in Animal Welfare Act no. 55. Additionally, the regulation includes the following appendices: I. Activities requiring assessment; II. Specifications for stable dimensions, ventilation, and noise levels in stables and events; III. Guidelines for carcass evaluation. Integrating Alternative Therapies into Equine Healthcare The Equine Healthcare Market is ripe with growth opportunities driven by various factors. Personalized medicine stands out as a significant avenue, with the customization of treatments based on individual horse characteristics leading to optimized health outcomes. Telemedicine and remote monitoring technologies, exemplified by platforms like VetNOW, enhance accessibility to healthcare services, fostering market expansion. Additionally, the rising demand for natural remedies fuels the growth of nutraceuticals and functional foods, such as omega-3 fatty acid supplements, catering to horse owners' preference for holistic healthcare options. Advancements in regenerative therapies like platelet-rich plasma (PRP) and mesenchymal stem cell treatment offer promising prospects by promoting tissue repair and regeneration. Digital health platforms such as Equinosis Q with Lameness Locator facilitate data-driven decision-making, improving diagnosis and treatment efficacy in equine healthcare. Integrating alternative therapies such as acupuncture and chiropractic care into mainstream healthcare further expands the market's offerings, meeting the demand for holistic approaches to equine health. Preventive medicine remains a key focus, with companies like Zoetis offering comprehensive preventive care packages to address the growing need for proactive health management. Expanding into emerging markets in Asia-Pacific and Latin America taps into new growth opportunities, fueled by rising disposable incomes and increasing awareness of animal health. Equine rehabilitation services and education/training programs for stakeholders round out the growth prospects, providing specialized care and empowering individuals with knowledge, respectively. Overall, these opportunities propel the Equine Healthcare Market, driving innovation for the Equine Healthcare Market.
Breed Category/Ownership Estimated Number Nonthoroughbred Breeders 1,100 Sport/Competition Horses 2,230 Recreational 23,850 Ancillary 5,120 Thoroughbred Breeders 1,140 Owners (i.e., in Training) 810 Total 34,250 Equine Healthcare Market Segment Analysis
Based on Product Type, the market has been divided into Drugs, Vaccines, and Supplemental Feed Additives. Among these, the Drugs sub-segment is projected to generate the maximum revenue. The Drugs sub-segment witnessed the highest market share in the global bike camera market in 2023. These medications play a pivotal role in maintaining the health and well-being of horses, offering treatments for pain management, inflammation, infections, and specific diseases like equine influenza and West Nile virus. The diversity of drugs available caters to the varied healthcare needs of horses, ranging from everyday health maintenance to the management of acute and chronic conditions. The high market share reflects the critical importance of drugs in the equine healthcare industry, as horse owners and veterinarians rely on these treatments to address the health challenges faced by their animals effectively. The prevalence of various health conditions in horses necessitates the availability of effective treatments, driving demand for a diverse range of medications. Additionally, ongoing advancements in veterinary medicine lead to the continuous development of new and improved drugs, expanding the treatment options available for equine healthcare providers and owners. Furthermore, the evolving landscape of equine healthcare, including changing disease patterns and emerging health threats, further underscores the importance of the Drugs sub-segment in meeting the healthcare needs of horses which boost Equine Healthcare Market. Competitive Landscape: In September 2022, Zoetis completed the acquisition of NewMetrica, an animal health research institute. The objective behind this acquisition was to pioneer innovative approaches aimed at transforming veterinary care and promoting animal welfare on a broader scale. The emphasis was on achieving exceptional standards of life quality for companion animals. Similarly, in April 2022, Boehringer Ingelheim International GmbH introduced renuTend, a groundbreaking stem cell therapy crafted to accelerate the healing process of tendon and suspensory ligament injuries in horses. This product launch provided veterinarians with a novel therapeutic option for addressing such injuries, enabling the company to enhance its existing portfolio and drive revenue through product sales.Equine Healthcare Market Scope: Inquire before buying
Global Equine Healthcare Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 1.7 Bn. Forecast Period 2024 to 2030 CAGR: 6.1% Market Size in 2030: US $ 2.57 Bn. Segments Covered: by Product Type Drugs Vaccines Supplemental Feed Additives by Disease Type Equine Influenza Rhinopneumonitis/ Equine Infectious Anemia West Nile Virus Equine Rabies Potomac Horse Fever Tetanus(Lockjaw) Other by Distribution Channel Veterinary Hospitals Clinics Retail Pharmacies Drug Stores Others Equine Healthcare Market, by Region:
North America (United States, Canada, and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, and the Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan, and the Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria, and the Rest of ME&A) South America (Brazil, Argentina Rest of South America)Equine Healthcare Market Key Players:
Major Contributors in the Equine Healthcare Market in North America: 1. Zoetis Inc. (United States) 2. Merck & Co., Inc. (United States) 3. Elanco Animal Health Incorporated (United States) 4. Dechra Pharmaceuticals PLC (United Kingdom) 5. IDEXX Laboratories, Inc. (United States) 6. Purina Animal Nutrition LLC (United States) 7. The J.M. Smucker Company (United States) 8. Kemin Industries, Inc. (United States) 9. Central Garden & Pet Company (United States) 10. Neogen Corporation (United States) Major Leading Player in the Equine Healthcare Market in Europe: 1. Boehringer Ingelheim GmbH (Germany) 2. Bayer AG (Germany) 3. Ceva Santé Animale (France) 4. Vetoquinol S.A. (France) 5. Virbac (France) 6. Merial Limited (France) 7. Norbrook Laboratories Limited (United Kingdom) 8. Equine Products UK Limited (United Kingdom) 9. Bimeda Holdings PLC (Ireland) 10. Huvepharma (Bulgaria) FAQ: 1] What segments are covered in the Global Equine Healthcare Market report? Ans. The segments covered in the Equine Healthcare Market report are based on Product Disease Type, Distribution Channel, and Region. 2] Which region is expected to hold the highest share in the Global Equine Healthcare Market? Ans. North America region is expected to hold the highest market share in the Equine Healthcare market. 3] What is the market size of the Global Equine Healthcare Market by 2030? Ans. The market size of the Equine Healthcare Market by 2030 is expected to reach USD 2.57 Billion. 4] What is the forecast period for the Global Equine Healthcare Market? Ans. The forecast period for the Equine Healthcare Market is 2024-2030. 5] What was the market size of the Global Equine Healthcare Market in 2023? Ans. The market size of the Equine Healthcare Market in 2023 was valued at USD 1.7 Billion.
1. Equine Healthcare Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Equine Healthcare Market: Dynamics 2.1. Equine Healthcare Market Trends by Region 2.1.1. North America Equine Healthcare Market Trends 2.1.2. Europe Equine Healthcare Market Trends 2.1.3. Asia Pacific Equine Healthcare Market Trends 2.1.4. Middle East and Africa Equine Healthcare Market Trends 2.1.5. South America Equine Healthcare Market Trends 2.2. Equine Healthcare Market Dynamics by Region 2.2.1. North America 2.2.1.1. North America Equine Healthcare Market Drivers 2.2.1.2. North America Equine Healthcare Market Restraints 2.2.1.3. North America Equine Healthcare Market Opportunities 2.2.1.4. North America Equine Healthcare Market Challenges 2.2.2. Europe 2.2.2.1. Europe Equine Healthcare Market Drivers 2.2.2.2. Europe Equine Healthcare Market Restraints 2.2.2.3. Europe Equine Healthcare Market Opportunities 2.2.2.4. Europe Equine Healthcare Market Challenges 2.2.3. Asia Pacific 2.2.3.1. Asia Pacific Equine Healthcare Market Drivers 2.2.3.2. Asia Pacific Equine Healthcare Market Restraints 2.2.3.3. Asia Pacific Equine Healthcare Market Opportunities 2.2.3.4. Asia Pacific Equine Healthcare Market Challenges 2.2.4. Middle East and Africa 2.2.4.1. Middle East and Africa Equine Healthcare Market Drivers 2.2.4.2. Middle East and Africa Equine Healthcare Market Restraints 2.2.4.3. Middle East and Africa Equine Healthcare Market Opportunities 2.2.4.4. Middle East and Africa Equine Healthcare Market Challenges 2.2.5. South America 2.2.5.1. South America Equine Healthcare Market Drivers 2.2.5.2. South America Equine Healthcare Market Restraints 2.2.5.3. South America Equine Healthcare Market Opportunities 2.2.5.4. South America Equine Healthcare Market Challenges 2.3. PORTER’s Five Forces Analysis 2.4. PESTLE Analysis 2.5. Technology Roadmap 2.6. Regulatory Landscape by Region 2.6.1. North America 2.6.2. Europe 2.6.3. Asia Pacific 2.6.4. Middle East and Africa 2.6.5. South America 2.7. Key Opinion Leader Analysis For Equine Healthcare Industry 2.8. Analysis of Government Schemes and Initiatives For Equine Healthcare Industry 2.9. Equine Healthcare Market Trade Analysis 2.10. The Global Pandemic Impact on Equine Healthcare Market 3. Equine Healthcare Market: Global Market Size and Forecast by Segmentation by Demand and Supply Side (by Value in USD Million) 2023-2030 3.1. Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 3.1.1. Drugs 3.1.2. Vaccines 3.1.3. Supplemental Feed Additives 3.2. Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 3.2.1. Equine Influenza 3.2.2. Rhinopneumonitis/ Equine Infectious Anemia 3.2.3. West Nile Virus 3.2.4. Equine Rabies 3.2.5. Potomac Horse Fever 3.2.6. Tetanus(Lockjaw) 3.2.7. Other 3.3. Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 3.3.1. Veterinary Hospitals 3.3.2. Clinics 3.3.3. Retail Pharmacies 3.3.4. Drug Stores 3.3.5. Others 3.4. Equine Healthcare Market Size and Forecast, by Region (2023-2030) 3.4.1. North America 3.4.2. Europe 3.4.3. Asia Pacific 3.4.4. Middle East and Africa 3.4.5. South America 4. North America Equine Healthcare Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 4.1. North America Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Drugs 4.1.2. Vaccines 4.1.3. Supplemental Feed Additives 4.2. North America Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 4.2.1. Equine Influenza 4.2.2. Rhinopneumonitis/ Equine Infectious Anemia 4.2.3. West Nile Virus 4.2.4. Equine Rabies 4.2.5. Potomac Horse Fever 4.2.6. Tetanus(Lockjaw) 4.2.7. Other 4.3. North America Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 4.3.1. Veterinary Hospitals 4.3.2. Clinics 4.3.3. Retail Pharmacies 4.3.4. Drug Stores 4.3.5. Others 4.4. North America Equine Healthcare Market Size and Forecast, by Country (2023-2030) 4.4.1. United States 4.4.1.1. United States Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 4.4.1.1.1. Drugs 4.4.1.1.2. Vaccines 4.4.1.1.3. Supplemental Feed Additives 4.4.1.2. United States Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 4.4.1.2.1. Equine Influenza 4.4.1.2.2. Rhinopneumonitis/ Equine Infectious Anemia 4.4.1.2.3. West Nile Virus 4.4.1.2.4. Equine Rabies 4.4.1.2.5. Potomac Horse Fever 4.4.1.2.6. Tetanus(Lockjaw) 4.4.1.2.7. Other 4.4.1.3. United States Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 4.4.1.3.1. Veterinary Hospitals 4.4.1.3.2. Clinics 4.4.1.3.3. Retail Pharmacies 4.4.1.3.4. Drug Stores 4.4.1.3.5. Others 4.4.2. Canada 4.4.2.1. Canada Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 4.4.2.1.1. Drugs 4.4.2.1.2. Vaccines 4.4.2.1.3. Supplemental Feed Additives 4.4.2.2. Canada Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 4.4.2.2.1. Equine Influenza 4.4.2.2.2. Rhinopneumonitis/ Equine Infectious Anemia 4.4.2.2.3. West Nile Virus 4.4.2.2.4. Equine Rabies 4.4.2.2.5. Potomac Horse Fever 4.4.2.2.6. Tetanus(Lockjaw) 4.4.2.2.7. Other 4.4.2.3. Canada Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 4.4.2.3.1. Veterinary Hospitals 4.4.2.3.2. Clinics 4.4.2.3.3. Retail Pharmacies 4.4.2.3.4. Drug Stores 4.4.2.3.5. Others 4.4.3. Mexico 4.4.3.1. Mexico Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 4.4.3.1.1. Drugs 4.4.3.1.2. Vaccines 4.4.3.1.3. Supplemental Feed Additives 4.4.3.2. Mexico Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 4.4.3.2.1. Equine Influenza 4.4.3.2.2. Rhinopneumonitis/ Equine Infectious Anemia 4.4.3.2.3. West Nile Virus 4.4.3.2.4. Equine Rabies 4.4.3.2.5. Potomac Horse Fever 4.4.3.2.6. Tetanus(Lockjaw) 4.4.3.2.7. Other 4.4.3.3. Mexico Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 4.4.3.3.1. Veterinary Hospitals 4.4.3.3.2. Clinics 4.4.3.3.3. Retail Pharmacies 4.4.3.3.4. Drug Stores 4.4.3.3.5. Others 5. Europe Equine Healthcare Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 5.1. Europe Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.2. Europe Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.3. Europe Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4. Europe Equine Healthcare Market Size and Forecast, by Country (2023-2030) 5.4.1. United Kingdom 5.4.1.1. United Kingdom Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.1.2. United Kingdom Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.1.3. United Kingdom Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.2. France 5.4.2.1. France Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.2.2. France Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.2.3. France Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.3. Germany 5.4.3.1. Germany Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.3.2. Germany Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.3.3. Germany Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.4. Italy 5.4.4.1. Italy Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.4.2. Italy Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.4.3. Italy Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.5. Spain 5.4.5.1. Spain Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.5.2. Spain Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.5.3. Spain Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.6. Sweden 5.4.6.1. Sweden Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.6.2. Sweden Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.6.3. Sweden Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.7. Austria 5.4.7.1. Austria Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.7.2. Austria Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.7.3. Austria Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 5.4.8. Rest of Europe 5.4.8.1. Rest of Europe Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 5.4.8.2. Rest of Europe Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 5.4.8.3. Rest of Europe Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6. Asia Pacific Equine Healthcare Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 6.1. Asia Pacific Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.2. Asia Pacific Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.3. Asia Pacific Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4. Asia Pacific Equine Healthcare Market Size and Forecast, by Country (2023-2030) 6.4.1. China 6.4.1.1. China Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.1.2. China Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.1.3. China Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.2. S Korea 6.4.2.1. S Korea Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.2.2. S Korea Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.2.3. S Korea Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.3. Japan 6.4.3.1. Japan Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.3.2. Japan Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.3.3. Japan Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.4. India 6.4.4.1. India Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.4.2. India Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.4.3. India Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.5. Australia 6.4.5.1. Australia Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.5.2. Australia Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.5.3. Australia Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.6. Indonesia 6.4.6.1. Indonesia Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.6.2. Indonesia Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.6.3. Indonesia Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.7. Malaysia 6.4.7.1. Malaysia Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.7.2. Malaysia Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.7.3. Malaysia Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.8. Vietnam 6.4.8.1. Vietnam Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.8.2. Vietnam Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.8.3. Vietnam Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.9. Taiwan 6.4.9.1. Taiwan Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.9.2. Taiwan Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.9.3. Taiwan Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 6.4.10. Rest of Asia Pacific 6.4.10.1. Rest of Asia Pacific Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 6.4.10.2. Rest of Asia Pacific Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 6.4.10.3. Rest of Asia Pacific Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 7. Middle East and Africa Equine Healthcare Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 7.1. Middle East and Africa Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 7.2. Middle East and Africa Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 7.3. Middle East and Africa Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 7.4. Middle East and Africa Equine Healthcare Market Size and Forecast, by Country (2023-2030) 7.4.1. South Africa 7.4.1.1. South Africa Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 7.4.1.2. South Africa Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 7.4.1.3. South Africa Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 7.4.2. GCC 7.4.2.1. GCC Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 7.4.2.2. GCC Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 7.4.2.3. GCC Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 7.4.3. Nigeria 7.4.3.1. Nigeria Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 7.4.3.2. Nigeria Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 7.4.3.3. Nigeria Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 7.4.4. Rest of ME&A 7.4.4.1. Rest of ME&A Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 7.4.4.2. Rest of ME&A Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 7.4.4.3. Rest of ME&A Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 8. South America Equine Healthcare Market Size and Forecast by Segmentation (by Value in USD Million) 2023-2030 8.1. South America Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 8.2. South America Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 8.3. South America Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 8.4. South America Equine Healthcare Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 8.4.1.2. Brazil Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 8.4.1.3. Brazil Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 8.4.2.2. Argentina Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 8.4.2.3. Argentina Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest Of South America Equine Healthcare Market Size and Forecast, by Product Type (2023-2030) 8.4.3.2. Rest Of South America Equine Healthcare Market Size and Forecast, by Disease Type (2023-2030) 8.4.3.3. Rest Of South America Equine Healthcare Market Size and Forecast, by Distribution Channel (2023-2030) 9. Global Equine Healthcare Market: Competitive Landscape 9.1. MMR Competition Matrix 9.2. Competitive Landscape 9.3. Key Players Benchmarking 9.3.1. Company Name 9.3.2. Business Segment 9.3.3. End-user Segment 9.3.4. Revenue (2022) 9.3.5. Company Locations 9.4. Leading Equine Healthcare Market Companies, by market capitalization 9.5. Market Structure 9.5.1. Market Leaders 9.5.2. Market Followers 9.5.3. Emerging Players 9.6. Mergers and Acquisitions Details 10. Company Profile: Key Players 10.1. Zoetis Inc. (United States) 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Scale of Operation (small, medium, and large) 10.1.7. Details on Partnership 10.1.8. Regulatory Accreditations and Certifications Received by Them 10.1.9. Awards Received by the Firm 10.1.10. Recent Developments 10.2. Merck & Co., Inc. (United States) 10.3. Elanco Animal Health Incorporated (United States) 10.4. Dechra Pharmaceuticals PLC (United Kingdom) 10.5. IDEXX Laboratories, Inc. (United States) 10.6. Purina Animal Nutrition LLC (United States) 10.7. The J.M. Smucker Company (United States) 10.8. Kemin Industries, Inc. (United States) 10.9. Central Garden & Pet Company (United States) 10.10. Neogen Corporation (United States) 10.11. Boehringer Ingelheim GmbH (Germany) 10.12. Bayer AG (Germany) 10.13. Ceva Santé Animale (France) 10.14. Vetoquinol S.A. (France) 10.15. Virbac (France) 10.16. Merial Limited (France) 10.17. Norbrook Laboratories Limited (United Kingdom) 10.18. Equine Products UK Limited (United Kingdom) 10.19. Bimeda Holdings PLC (Ireland) 10.20. Huvepharma (Bulgaria) 11. Key Findings 12. Industry Recommendations 13. Equine Healthcare Market: Research Methodology 14. Terms and Glossary
